New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
July 28, 2014
09:03 EDTELOSSyneron Medical's Picoway skin device granted CE Mark
Syneron Medical's new PicoWay device has received CE Mark indication to treat tattoos of all types and colors and pigmented lesions on any skin type. Syneron will begin a staged launch of the PicoWay device in the international market during Q3 and anticipates that it will receive FDA clearance for PicoWay by the end of 2014.
News For ELOS From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
June 25, 2015
07:01 EDTELOSSyneron Medical announces results of clinical trial for Profound
Syneron Medical released the results of a new clinical trial for Profound, an innovative radiofrequency device clinically proven to improve facial and neck wrinkles without surgery. The current results suggest that with optimal settings, a Profound treatment can produce up to 89% of the laxity improvement results of a surgical facelift. With the new protocol for optimal settings to produce superior results, patients can realize many of the benefits approaching the surgical facelift with this novel minimally invasive in-office 30-minute treatment. The breakthrough technology meets the demands of today's consumers. In a recent survey, more than half of women with sagging jaw lines and "turkey necks" have considered nonsurgical treatment. Unlike facelifts, which require general anesthesia, long incisions, and recovery, Profound patients typically experience only minor redness that resolves within two to 12 hours and minimal swelling for up to five days. Most patients can resume normal activities within 24-48 hours.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the disclaimer & terms of use